The Debut of Vedolizumab for Inflammatory Bowel Disease

Dr. David Johnson discusses the newly approved drug for both ulcerative colitis and Crohn disease that more closely targets gut inflammation, and may be a boon for patients.
Source: Medscape Pharmacists Podcast - Category: Drugs & Pharmacology Authors: Source Type: podcasts